It was another quiet month for new arrivals to AIM, with the difficult stock market putting-off newcomers. With shares tumbling and valuations looking far more attractive, private equity is taking a keen interest, with the likelihood that AIM’s numbers may decline further as good quality companies are snapped up for bargain prices.
At the end of April 2022 there were 842 companies on AIM, with the total market value of London's growth market £122 billion. This compares to 844 companies at the end of March, when AIM’s market value was £126 billion. There was 1 new arrival in the month, a transfer from the Main Market, and 3 departures. Leavers in the period included pharmaceuticals group Clinigen, which was acquired by UK-based private equity firm Triton for £1.3 billion, thereby representing a large element of AIM’s decline in value - the AIM index fell 1.92% in the month. With the value of…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login